000			05095nam a22005295i 4500
001			206174
003			IT-RoAPU
005			20221214233552.0
006			m|||||o||d||||||||
007			cr || ||||||||
008			210824t20142010nju fo d z eng d
020			_a9780691141800 _qprint
020			_a9781400835119 _qPDF
024	7		_a10.1515/9781400835119 _2doi
035			_a(DE-B1597)9781400835119
035			_a(DE-B1597)446670
035			_a(OCoLC)979745514
040			_aDE-B1597 _beng _cDE-B1597 _erda
050		4	_aRA401.A3C37 2010
072		7	_aPOL028000 _2bisacsh
082	0	4	_a322.30973 _a362.17/82
084			_aonline - DeGruyter
100	1		_aCarpenter, Daniel _eautore
245	1	0	_aReputation and Power : _bOrganizational Image and Pharmaceutical Regulation at the FDA / _cDaniel Carpenter.
250			_aCourse Book
264		1	_aPrinceton, NJ : _bPrinceton University Press, _c[2014]
264		4	_c©2010
300			_a1 online resource (856 p.) : _b13 halftones. 17 line illus. 13 tables.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
490	0		_aPrinceton Studies in American Politics: Historical, International, and Comparative Perspectives ; _v137
505	0	0	_tFrontmatter -- _tContents -- _tList of Illustrations -- _tList of Tables -- _tAcknowledgments -- _tList of Abbreviations and Acronyms -- _tIntroduction. The Gatekeeper -- _tChapter One. Reputation and Regulatory Power -- _tPart One: Organizational Empowerment and Challenge -- _tChapter Two. Reputation and Gatekeeping Authority: The Federal Food, Drug and Cosmetic Act of 1938 and Its Aftermath -- _tChapter Three. The Ambiguous Emergence of American Pharmaceutical Regulation, 1944-1961 -- _tChapter Four. Reputation and Power Crystallized: Thalidomide, Frances Kelsey, and Phased Experiment, 1961-1966 -- _tChapter Five. Reputation and Power Institutionalized: Scientific Networks, Congressional Hearings, and Judicial Affirmation, 1963-1986 -- _tChapter Six. Reputation and Power Contested: Emboldened Audiences in Cancer and Aids, 1977-1992 -- _tPart Two: Pharmaceutical Regulation and Its Audiences -- _tChapter Seven. Reputation and the Organizational Politics of New Drug Review -- _tChapter Eight. The Governance of Research and Development: Gatekeeping Power, Conceptual Guidance, and Regulation by Satellite -- _tChapter Nine. The Other Side of the Gate: Reputation, Power, and Post-Market Regulation -- _tChapter Ten. The Détente of Firm and Regulator -- _tChapter Eleven. American Pharmaceutical Regulation in International Context: Audiences, Comparisons, and Dependencies -- _tChapter Twelve. Conclusion: A Reputation in Relief -- _tPrimary Sources and Archival Collections -- _tIndex
506	0		_arestricted access _uhttp://purl.org/coar/access_right/c_16ec _fonline access with authorization _2star
520			_aThe U.S. Food and Drug Administration is the most powerful regulatory agency in the world. How did the FDA become so influential? And how exactly does it wield its extraordinary power? Reputation and Power traces the history of FDA regulation of pharmaceuticals, revealing how the agency's organizational reputation has been the primary source of its power, yet also one of its ultimate constraints. Daniel Carpenter describes how the FDA cultivated a reputation for competence and vigilance throughout the last century, and how this organizational image has enabled the agency to regulate an industry as powerful as American pharmaceuticals while resisting efforts to curb its own authority. Carpenter explains how the FDA's reputation and power have played out among committees in Congress, and with drug companies, advocacy groups, the media, research hospitals and universities, and governments in Europe and India. He shows how FDA regulatory power has influenced the way that business, medicine, and science are conducted in the United States and worldwide. Along the way, Carpenter offers new insights into the therapeutic revolution of the 1940s and 1950s; the 1980s AIDS crisis; the advent of oral contraceptives and cancer chemotherapy; the rise of antiregulatory conservatism; and the FDA's waning influence in drug regulation today. Reputation and Power demonstrates how reputation shapes the power and behavior of government agencies, and sheds new light on how that power is used and contested.Some images inside the book are unavailable due to digital copyright restrictions.
530			_aIssued also in print.
538			_aMode of access: Internet via World Wide Web.
546			_aIn English.
588	0		_aDescription based on online resource; title from PDF title page (publisher's Web site, viewed 24. Aug 2021)
650		7	_aPOLITICAL SCIENCE / Public Policy / General. _2bisacsh
850			_aIT-RoAPU
856	4	0	_uhttps://doi.org/10.1515/9781400835119
856	4	0	_uhttps://www.degruyter.com/isbn/9781400835119
856	4	2	_3Cover _uhttps://www.degruyter.com/cover/covers/9781400835119.jpg
942			_cEB
999			_c206174 _d206174